Pricing Log in Create free account

Context Therapeutics Inc. (CNTX) vs Cocrystal Pharma, Inc. (COCP)

Context Therapeutics Inc. and Cocrystal Pharma, Inc. are both Biotechnology companies. Context Therapeutics Inc. is the larger, with a market value of $22.1M against $19.8M — 1.1× the size. Context Therapeutics Inc. has the higher net margin (0.00% vs −747.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Context Therapeutics Inc. leads on 7 and Cocrystal Pharma, Inc. on 5.

Valuation

Metric CNTX COCP Biotechnology median
P/E n/m n/m 8.50
P/S n/m 10.58 9.71
P/B 0.60 13.47 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.41 n/m 0.64
EV/Sales n/m 8.90 9.21
Earnings yield (200.00%) (74.51%) (33.15%)
Free cash flow yield (148.95%) (56.64%) (25.50%)

Profitability

Metric CNTX COCP Biotechnology median
Gross margin 0.00% 9.10% 65.16%
Operating margin 0.00% (760.72%) 0.00%
Net margin 0.00% (747.78%) 0.00%
Free cash flow margin 0.00% (598.50%) 0.00%
Return on equity (76.14%) (311.68%) (56.36%)
Return on assets (68.96%) (151.10%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CNTX COCP Biotechnology median
Revenue growth (TTM) — (30.38%) 6.02%
EPS growth (last fiscal year) 17.39% 54.65% 30.26%
Revenue growth, 5-year CAGR — (33.30%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTX COCP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.81 1.24 4.72
Net debt to EBITDA 1.66 0.82 0.96

Dividend

Metric CNTX COCP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CNTX COCP Biotechnology median
Market cap 22.09m 19.84m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack